<DOC>
	<DOCNO>NCT01930981</DOCNO>
	<brief_summary>We interest study whether medical problem primary cancer hematopoietic cell transplantation would impact profile quality life toxicity post-transplantation patient blood cancer . We want see assess comorbidities ( diabetes ) early , identify patient toxicity limitation quality life transplant . The generated information could set stage future intervention study aim improve quality life patient blood cancer transplantation .</brief_summary>
	<brief_title>Associations Between Pre-transplant Comorbidities Post-transplant Toxicities Quality Life</brief_title>
	<detailed_description />
	<criteria>Allogeneic HCT candidate &gt; 18 year age Able speak read English Able provide inform consent Access telephone studyrelated communication Diagnosed hematological malignant disease Willing complete survey packets 5 timepoints , span two year HCT candidate 18 year young time study enrollment HCT candidate read , write , speak English Patients diagnose nonmalignant disease , solid tumor primary disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>quality life</keyword>
	<keyword>toxicity</keyword>
	<keyword>hematopoietic stem cell transplantation</keyword>
</DOC>